Agoracom: Small Cap Investment - Resverlogix Corp. - Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients

KOO-KOO2

Jun 12, 2023 07:23AM

Nextblockbuster

Rank: President [?]

Points: 2670 [?]

Votes: 15 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients

in response to

Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients

KOO-KOO2

posted on Jun 12, 2023 06:15PM

RVX puts out a NR that gets ignored by the market while a peer biotech gets bought out by BP for $3.5 Billion

https://investors.chinooktx.com/news-releases/news-release-details/chinook-therapeutics-enters-agreement-be-acquired-novartis-ag

2 Recommendations

Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients

10BagR

Jun 13, 2023 08:02AM

Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients

10BagR

Jun 13, 2023 08:21AM

Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients

Toinv

Jun 13, 2023 09:08AM

Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients

tada

Jun 13, 2023 11:58AM

Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients

jonzobot

Jun 13, 2023 12:32PM

Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients

Buckeyes

Jun 13, 2023 12:33PM

Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients

10BagR

Jun 13, 2023 05:38PM

Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients

cityslicker99

Jun 13, 2023 07:24PM

Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients

cityslicker99

Jun 13, 2023 07:25PM

Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients

KOO-KOO2

Jun 14, 2023 07:25AM

Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients

tada

Jun 14, 2023 09:18AM

Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients

Carman2

Jun 14, 2023 03:46PM

Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients